stella
beta
Establish Diagnostic and Prognostic Models for Preclinical AD Patients Based on Multimodal MRI, Behavioral, Genetic, and Plasma Biomarkers — Stella
Home
/
Alzheimer Disease, Late Onset
/
Establish Diagnostic and Prognostic Models for Preclinical AD Patients Based on Multimodal MRI, Behavioral, Genetic, and Plasma Biomarkers
View on ClinicalTrials.gov
Recruiting
Back to Alzheimer Disease, Late Onset trials
Establish Diagnostic and Prognostic Models for Preclinical AD Patients Based on Multimodal MRI, Behavioral, Genetic, and Plasma Biomarkers
Trial locations
(1 site)
China
Nanjing Drum Tower Hospital, Nanjing, Jiangsu